Drug application

SILDENAFIL CITRATE (SILDENAFIL CITRATE)

Drugs@FDA ANDA 200165 · ACTAVIS PHARMA

Key facts

Drug name SILDENAFIL CITRATE
Active ingredients SILDENAFIL CITRATE
Application type ANDA
Application number 200165
Company ACTAVIS PHARMA
Dosage forms TABLET, ORAL
Strength 25MG
Marketing status None (Tentative Approval)
Reference listed drug No
Latest submission class Not Applicable
Latest submission status date Feb 25, 2013

At a glance

  • 1–9 Submissions
  • None Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA

Browse all Drugs@FDA applications